Lucid Diagnostics Inc.
About Lucid Diagnostics Inc.
Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2024
- $4.3M
- Net income
- -$58.0M
- Total assets
- $40.4M
- Market cap
- $184.5M
- Gross margin
- -41.7%
- Operating margin
- -1054.8%
- Net margin
- -1232.7%
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $4.7M
- Cost of revenue
- $6.7M
- Gross profit
- -$2.0M
- Operating expenses
- $47.7M
- Operating income
- -$49.6M
- Income tax
- $0
- Net income
- -$58.0M
- EPS (basic)
- $-0.69
Balance sheet
- Total assets
- $40.4M
- Current assets
- $37.5M
- Total liabilities
- $29.5M
- Current liabilities
- $28.6M
- Shareholders’ equity
- $10.9M
Cash flow
- Operating cash flow
- -$46.5M
- Investing cash flow
- -$197.0K
- Financing cash flow
- $59.0M
- Net cash flow
- $12.3M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year
52-week range
- Market cap
- $184.5M
- Shares outstanding
- 192.2M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Oct 14, 2021
Market data by Polygon.io · prices are 15-minute delayed
At a glance
- Reported a net loss of $58.0M in FY2024.
- Revenue grew 5636% from FY2021 to FY2025.
- Gross margin of -41.7%, net margin -1232.7%.
- Trading 40% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Lucid Diagnostics Inc..
Write a review
News about Lucid Diagnostics Inc.
News & sentiment via Polygon.io
